Electrolyte disturbance associated with jejunal conduit.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D002295:Carcinoma, Transitional Cell / Q000601:surgery; D002648:Child; D004231:Diuresis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006869:Hydronephrosis / Q000209:etiology / Q000601:surgery; D006947:Hyperkalemia / Q000188:drug therapy / Q000209:etiology*; D007010:Hyponatremia / Q000188:drug therapy / Q000209:etiology*; D007223:Infant; D007408:Intestinal Absorption; D007583:Jejunum / Q000601:surgery*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011188:Potassium / Q000378:metabolism; D011782:Quadriplegia / Q000601:surgery; D012964:Sodium / Q000378:metabolism; D012965:Sodium Chloride / Q000627:therapeutic use; D016135:Spinal Dysraphism / Q000601:surgery; D013577:Syndrome; D014511:Uremia / Q000188:drug therapy / Q000209:etiology*; D014513:Ureter / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000601:surgery; D014547:Urinary Diversion / Q000009:adverse effects*; D014882:Water-Electrolyte Balance
D012965:Sodium Chloride; D012964:Sodium; D011188:Potassium